Eli Lilly Making Moves
So Eli Lilly's out here doing the most ramping up capacity for their incretin drugs. Looks like they're not playing around with Zepbound and Mounjaro. Big things poppin' in North Carolina Indiana Ireland and Germany.
Novo Nordisk's Not So Smooth Sailing
Novo Nordisk on the other hand seems to be facing some rough waters. They're struggling to keep up with the demand for Wegovy and Ozempic. Sounds like they need to step up their game!
Apple Watches Your Heart
Apple's getting some love from the FDA for their heart monitoring tech. Atrial Fibrillation History feature is making waves in clinical studies. Who knew your watch could keep such a close eye on your heart?
Snoop Dogg drugmakers supply struggles FDA approval Apple Watch health tech Eli Lilly Novo Nordisk weight loss drugs diabetes medications
Comments
- No comments yet. Become a member to post your comments.